Replies to post #674617 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Thanks Chiugray, imagine our potential with off label use once it is sufficiently proven that insurance will pay for it.

Gary

[CrashOverride]

Flaskworks is 12X more productive than manual clean rooms but also smaller. So I believe Sawston will very likely have higher capacity than 144K patients per year.

[drugrunner]

At 1.5B shares outstanding .. the share price would project around $60 when comparing to Gilead

[eagle8]

Chiugray,
Question: There has been a discussion based on the Hyperopia piece about the press release regarding Flaskwork.
This was about the number of batches that can be produced per year.
First manually and then a factor of 12 with flaskworks instead of manual.
My specific question is whether Dr. Bosch, when he talks about the scaling up of Sawston to 1000 patients per month, really meant the manual method.
Because then we are indeed talking about 144 k patients per year.
And then I don't take into account the simple expansion of the Eden systems, which of course take up much less space and also require less qualitative space to install many units.
After official approval ofcourse.

Thanks in advance for an answer.
GLTU

[attilathehunt]

I wonder what the backup plan is in case of fire?

At least hopefully, they will have a market disruption insurance policy.

I wouldn't put anything past these low lives HFs/MMs.

They already, lie, cheat, steal and have no respect for the sanctity of life.